ABC News – Top stories
·general
·1 hour ago
Drug company refuses to subsidise diabetes medication that costs $700 a pop
Eli Lilly refused to subsidize its diabetes medication Mounjaro following stalled negotiations with the Australian government. Approximately 450,000 diabetics will miss out on discounted access, sparking criticism from Medicines Australia over the broken Pharmaceutical Benefits Scheme process. Health Minister Mark Butler is seeking advice on the matter as patients face high out-of-pocket costs.
Summary by Glance · ABC News – Top stories
Newer
Loving doing this? 🎉
Take it further — get the full app and never miss a moment of what's happening in Australia.
Breaking news alerts
Instant lock-screen notifications the moment big stories break across Australia.
Australian news & events
Politics, sport, weather, local events — all in one swipeable feed, updated around the clock.
Stay ahead of the news cycle
30-second summaries so you're always informed, even on your busiest days.
Loading article…
This publisher's site can't be shown here due to their security settings.
Open full article →No source link available for this article.
✨
Ask AI